1-10 of 10
Abid Mohiuddin
Close
Sort by
Journal Articles

Retrospective Observational Study on Multiple Myeloma Cases Admitted to Kfsh – Dammam Between 1st of June 2006 till the End of December 2013

Omar Zeid Abduljalil, MBBS, Abid Mohiuddin, MBBS, Hani Hassan Al Hashmi, MDFRCPC
Journal: Blood
Blood (2014) 124 (21): 5995.
https://doi.org/10.1182/blood.V124.21.5995.5995
Published: 2014
Journal Articles

Once a Week Bortezomib with Dexamethasone Is Effective with Limited Toxicity in Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities,

Nikhil C. Munshi, MD, Saem Lee, B.A., Suman Kambhampati, M.D., Michal Rose, M.D., Abid Mohiuddin, M.D., Yvonne Efebera, M.D., Andrew Han, B.A., Antoun Houranieh, RPh., M.S., Ph.D., Abraham Zimelman, M.D., Mary T. Brophy, M.D., Rao Prabhala, Ph.D., Terrence Grady, DO, PhD, Paulette Mehta, M.D, MPH, Teresa G Hayes, M.D., Sarvari Venkata Yellapragada, MBBS, MD, Caroline Behler, M.D., Catherine Klein, M.D., David Roodman, MD, PhD, Alan K. Lichtenstein, M.D.
Journal: Blood
Blood (2011) 118 (21): 3964.
https://doi.org/10.1182/blood.V118.21.3964.3964
Published: 2011
Journal Articles

Interim Results of An Ongoing Clinical Study Suggests Efficacy and Improved Toxicity Profile with Once a Week Bortezomib with Dexamethasone In Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities

Nikhil C. Munshi, M.D., Saem Lee, B.A., Suman Kambhampati, M.D., Abid Mohiuddin, M.D., Michal Rose, M.D., Caroline Behler, M.D., Andrew Han, B.A., Yvonne Efebera, M.D., Antoun Houranieh, RPh., M.S., Ph.D., Mary T. Brophy, M.D., Abraham Zimelman, M.D., Rao H Prabhala, Ph.D., Hussain I. Saba, M.D, Ph.D, Catherine Klein, M.D., Paulette Mehta, M.D, MPH, Teresa Hayes, M.D., David Roodman, M.D, Ph.D, Alan K. Lichtenstein, M.D.
Journal: Blood
Blood (2010) 116 (21): 3061.
https://doi.org/10.1182/blood.V116.21.3061.3061
Published: 2010
Journal Articles

Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3000 patients treated since 1989

Clinical Trials & Observations
Bart Barlogie, Guido Tricot, Jeff Haessler, Frits van Rhee, Michele Cottler-Fox, Elias Anaissie, James Waldron, Mauricio Pineda-Roman, Raymond Thertulien, Maurizio Zangari, Klaus Hollmig, Abid Mohiuddin, Yazan Alsayed, Antje Hoering, John Crowley, Jeffrey Sawyer
Journal: Blood
Blood (2008) 111 (1): 94–100.
https://doi.org/10.1182/blood-2007-06-097444
Published: 2008
Journal Articles

High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis

Clinical Trials & Observations
Frits van Rhee, Vanessa Bolejack, Klaus Hollmig, Mauricio Pineda-Roman, Elias Anaissie, Joshua Epstein, John D. Shaughnessy, Jr, Maurizio Zangari, Guido Tricot, Abid Mohiuddin, Yazan Alsayed, Gail Woods, John Crowley, Bart Barlogie
Journal: Blood
Blood (2007) 110 (3): 827–832.
https://doi.org/10.1182/blood-2007-01-067728
Published: 2007
Journal Articles

Total Therapies (TT) for Newly Diagnosed Patients with Multiple Myeloma (MM): Significant Benefit in High-Risk Disease with Cytogenetic Abnormalities (CA) over the Course of 17 Years.

Frits van Rhee, Vanessa Bolejack, Elias Anaissie, Guido Tricot, Klaus Hollmig, Maurizio Zangari, Mauricio Pineda-Roman, Abid Mohiuddin, Antje Hoering, John Crowley, Bart Barlogie
Journal: Blood
Blood (2006) 108 (11): 3490.
https://doi.org/10.1182/blood.V108.11.3490.3490
Published: 2006
Journal Articles

Rapidly Cycled Aggressive Lymphoma-Like Therapy (HD-DTPACE) for Salvage of Patients with Advanced Multiple Myeloma (MM).

Varant Arzoumanian, MD, Bart Barlogie, MD,PhD, Mauricio Pineda-Roman, MD, Klaus Hollmig, MD, Elias Anaissie, MD, Maurizio Zangari, MD, Somashekar Krishna, MD, Eilas Kiwan, MD, Guido Tricot, MD,PhD, Abid Mohiuddin, MD, Frits van Rhee, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 3561.
https://doi.org/10.1182/blood.V108.11.3561.3561
Published: 2006
Journal Articles

Treatment Associated Venous Thromboembolism (VTE) and Survival in Multiple Myeloma Patients.

Maurizio Zangari, MD, Federica Cavallo, MD, Louis M. Fink, MD, Bart Barlogie, MD, PhD, Vanessa Bolejack, BS, Michael J. Burns, Elias Anaissie, MD, Klaus A. Hollmig, MD, Abid Mohiuddin, MD, Mauricio Pineda-Roman, MD, Guido J. Tricot, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3573.
https://doi.org/10.1182/blood.V108.11.3573.3573
Published: 2006
Journal Articles

Retrospective Analysis of Fractionated High-Dose Melphalan (F-MEL) and Bortezomib-Thalidomide-Dexamethasone (VTD) with Autotransplant (AT) Support for Advanced and Refractory Multiple Myeloma (AR-MM).

Mauricio Pineda-Roman, MD, Michelle H. Fox, MD, Klaus A. Hollmig, MD, Elias J. Anaissie, MD, Frits van Rhee, MD,PhD, Guido Tricot, MD,PhD, Maurizio Zangari, MD, Abid Mohiuddin, MD, Bart Barlogie, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 3102.
https://doi.org/10.1182/blood.V108.11.3102.3102
Published: 2006
Journal Articles

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

John D. Shaughnessy, Jr, Fenghuang Zhan, Bart E. Burington, Yongsheng Huang, Simona Colla, Ichiro Hanamura, James P. Stewart, Bob Kordsmeier, Christopher Randolph, David R. Williams, Yan Xiao, Hongwei Xu, Joshua Epstein, Elias Anaissie, Somashekar G. Krishna, Michele Cottler-Fox, Klaus Hollmig, Abid Mohiuddin, Mauricio Pineda-Roman, Guido Tricot, Frits van Rhee, Jeffrey Sawyer, Yazan Alsayed, Ronald Walker, Maurizio Zangari, John Crowley, Bart Barlogie
Journal: Blood
Blood (2006) 109 (6): 2276–2284.
https://doi.org/10.1182/blood-2006-07-038430
Published: 2006